Ashvattha Therapeutics (Research Labs)
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company based in Baltimore, MD, specializing in the development of precision nanomedicines to address unmet medical needs in ophthalmology, neurology, and inflammatory diseases. Their innovative hydroxyl dendrimer HD technology enables the creation of targeted nanomedicines that selectively target activated cells in regions of inflammation, redefining precision medicine and offering a new standard of care.
With a focus on traversing tissue barriers, Ashvattha Therapeutics aims to treat diseases with unprecedented precision by developing nanomedicines that are selectively taken up by inflamed tissues. Their pipeline includes potential treatments for ophthalmic conditions, such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME), as well as neuroinflammation and other inflammatory diseases. Through their cutting-edge approach, Ashvattha Therapeutics is dedicated to advancing the field of precision medicine and improving patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
